Seeks to further amend notification No. 16/2017-Customs dated 20th April, 2017, which provides exemption to specified medicines under certain Patient Assistance Programmes (PAPs) run by pharmaceutical companies. Notification No. 41/2020-Customs dated 29th October, 2020
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(DEPARTMENT OF REVENUE)
Notification No. 41/2020-Customs
New Delhi, the 29th October, 2020
G.S.R. …(E). – In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act,1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do, hereby makes the following further amendments in the notification of the Government of India, in the Ministry of Finance (Department of Revenue), No. 16/2017-Customs, dated the 20th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R.394 (E), dated the 20th April, 2017, namely:-
In the said notification, in the Table, for the entries in column (3) and column (4) at the serial numbers given in column (1) of the Table below, the corresponding entries at column (2) and column (3) of the Table below shall be substituted, namely:-
Table
(1) | (2) | (3) |
17. | “Win for Patients- Cancer Care/ Umaang | Novartis Healthcare Private Limited |
1. | Win for Patients- Cancer Care/ Umaang | Novartis Healthcare Private Limited |
2. | Win for Patients- Cancer Care/ Umaang | Novartis Healthcare Private Limited |
3. | Win for Patients- Cancer Care/ Umaang | Sandoz India Private Limited |
4. | Win for Patients- Cancer Care/ Umaang | Novartis Healthcare Private Limited |
5. | Win for Patients- Cancer Care/ Umaang | Novartis Healthcare Private Limited |
43. | Sutent Patient Assistance Programme – STAR | Pfizer Products India Private Limited |
6. | Crizalk Patient Assistance Programme – STAR | Pfizer Products India Private Limited |
7. | Inlyta Patient Assistance Programme – STAR | Pfizer Products India Private Limited |
8. | Palbace Patient Assistance Programme – PRERNA | Pfizer Products India Private Limited |
9. | Enbrel Patient Assistance Programme | Pfizer Limited |
10. | Xeljanz Patient Assistance Programme | Pfizer Limited |
11. | Genotropin Patient Assistance Programme | Pfizer Products India Private Limited |
12. | Atgam Patient Assistance Programme | Pfizer Products India Private Limited |
13. | Aromasin Patient Assistance Programme | Pfizer Products India Private Limited |
14. | Campto Patient Assistance Programme | Pfizer Products India Private Limited”. |
[F. No. 332/24/2010-TRU (Pt.III)]
(Gaurav Singh)
Deputy Secretary to the Government of India
Note: The principal notification No. 16/2017-Customs, dated the 20th April, 2017 was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R.394 (E), dated the 20th April, 2017, and was last amended by notification No. 83/2017-Customs, dated the 31st October, 2017 published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide number G.S.R. 1356 (E), dated the 31st October, 2017.